Sinocare Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Operating Revenue	4,699	4,428	4,043	3,936	2,344	2,008
Other Revenue	15.22	15.22	15.66	16.53	17.01	7.2
Revenue	4,714	4,443	4,059	3,952	2,361	2,015
Revenue Growth (YoY)	12.10%	9.47%	2.69%	67.38%	17.17%	13.33%
Cost of Revenue	2,332	2,026	1,909	1,899	975.44	714.87
Gross Profit	2,383	2,417	2,150	2,054	1,386	1,300
Selling, General & Admin	1,743	1,597	1,399	1,325	903.08	734.96
Research & Development	320.72	375	356.41	306.31	182.43	182.49
Other Operating Expenses	48.74	-18.64	-26.79	-6.49	-24.7	-29.76
Operating Expenses	2,109	1,983	1,740	1,635	1,129	940.81
Operating Income	273.5	434.09	409.5	418.65	256.76	359.54
Interest Expense	-40.3	-47.47	-66.28	-67.74	-27.71	-12.91
Interest & Investment Income	23.81	20.51	18.66	12.18	10.6	10.36
Currency Exchange Gain (Loss)	12.32	12.32	9.99	25.79	-11.09	-9.3
Other Non Operating Income (Expenses)	-26.51	-4.38	-39.46	156.67	-7.39	-5.84
EBT Excluding Unusual Items	242.82	415.07	332.4	545.55	221.17	341.85
Impairment of Goodwill	-	-	-84.23	-6.94	-4.37	-31.6
Gain (Loss) on Sale of Investments	-32.63	-33.27	-	-	-80.5	-73.61
Gain (Loss) on Sale of Assets	6.36	0.96	-6	-0.64	0.12	-0.43
Asset Writedown	-18.04	-21.51	-8.86	-16.3	-11.39	-0.38
Legal Settlements	-0.5	-0.5	-	-	-	-
Other Unusual Items	69.43	34.52	15.26	16.98	13.14	11.95
Pretax Income	267.43	395.26	248.56	538.64	138.18	247.78
Income Tax Expense	40.46	49.41	52.72	47.95	31.16	60.89
Earnings From Continuing Operations	226.97	345.85	195.85	490.69	107.01	186.89
Minority Interest in Earnings	54.98	-19.56	88.55	-44.19	0.55	-
Net Income	281.95	326.29	284.4	446.51	107.57	186.89
Net Income to Common	281.95	326.29	284.4	446.51	107.57	186.89
Net Income Growth	27.17%	14.73%	-36.31%	315.09%	-42.44%	-25.45%
Shares Outstanding (Basic)	552	554	557	558	561	559
Shares Outstanding (Diluted)	552	554	557	558	561	559
Shares Change (YoY)	-0.58%	-0.52%	-0.24%	-0.57%	0.36%	-0.81%
EPS (Basic)	0.51	0.59	0.51	0.80	0.19	0.33
EPS (Diluted)	0.51	0.59	0.51	0.80	0.19	0.33
EPS Growth	27.92%	15.33%	-36.16%	317.48%	-42.65%	-24.84%
Free Cash Flow	588.96	444.62	388.54	362.13	76.23	229.08
Free Cash Flow Per Share	1.07	0.80	0.70	0.65	0.14	0.41
Dividend Per Share	0.220	0.220	0.200	0.200	0.200	0.200
Dividend Growth	10.00%	10.00%	-	-	-	-33.33%
Gross Margin	50.54%	54.40%	52.96%	51.96%	58.69%	64.53%
Operating Margin	5.80%	9.77%	10.09%	10.59%	10.87%	17.84%
Profit Margin	5.98%	7.34%	7.01%	11.30%	4.55%	9.27%
Free Cash Flow Margin	12.49%	10.01%	9.57%	9.16%	3.23%	11.37%
EBITDA	458.98	621.4	599.23	584.42	353.78	441.36
EBITDA Margin	9.74%	13.99%	14.76%	14.79%	14.98%	21.90%
D&A For EBITDA	185.48	187.3	189.73	165.78	97.02	81.83
EBIT	273.5	434.09	409.5	418.65	256.76	359.54
EBIT Margin	5.80%	9.77%	10.09%	10.59%	10.87%	17.84%
Effective Tax Rate	15.13%	12.50%	21.21%	8.90%	22.55%	24.57%
Revenue as Reported	4,714	4,443	4,059	3,952	-	2,015
Advertising Expenses	-	494.09	348.75	306.55	321.85	244.75

Source: S&P Global Market Intelligence. Standard template. Financial Sources.